Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial

Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial

Accepted Manuscript Seven-Day Intensive Preoperative Rehabilitation for Elderly Patients with Lung Cancer: A Randomized Controlled Trial Yutian Lai, M...

768KB Sizes 3 Downloads 161 Views

Accepted Manuscript Seven-Day Intensive Preoperative Rehabilitation for Elderly Patients with Lung Cancer: A Randomized Controlled Trial Yutian Lai, MD, Jian Huang, MD, Mei Yang, MD, Jianhua Su, PhD, Jing Liu, PhD, Guowei Che, MD PII:

S0022-4804(16)30416-4

DOI:

10.1016/j.jss.2016.09.033

Reference:

YJSRE 14001

To appear in:

Journal of Surgical Research

Received Date: 22 June 2016 Revised Date:

4 September 2016

Accepted Date: 21 September 2016

Please cite this article as: Lai Y, Huang J, Yang M, Su J, Liu J, Che G, Seven-Day Intensive Preoperative Rehabilitation for Elderly Patients with Lung Cancer: A Randomized Controlled Trial, Journal of Surgical Research (2016), doi: 10.1016/j.jss.2016.09.033. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Page 1

ACCEPTED MANUSCRIPT Title Page

1 2

Title: Seven-Day Intensive Preoperative Rehabilitation for Elderly Patients with Lung Cancer: A Randomized Controlled Trial

3

Running title: Modified pulmonary rehabilitation for elderly patients with lung cancer

5

Authors: Yutian Lai (MD)

1,*

, Jian Huang (MD)

(PhD) 3, Guowei Che (MD) 1,

6

RI PT

4

1,*,ψ

, Mei Yang (MD) 1, Jianhua Su (PhD) 2, Jing Liu

ψ

7

1

8

China

9

2

Rehabilitation Department, West China Hospital, Sichuan University, Chengdu 610041, P.R. China

10

3

West China School of Public Health, Sichuan University, Chengdu 610041, P.R. China

11

*

These authors contributed to the work equally and should be regarded as co-first authors.

12

ψ

Corresponding authors.

13

Conflict of interest statement

SC

M AN U

TE D

14

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, P.R.

The authors have no conflicts of interest to disclose. Funding

16

This study was supported by the Foundation of Science and Technology Support Plan, Department of

17

Sichuan Province (2014SZ0148 and 2015SZ0158).

18

Corresponding author:

AC C

EP

15

19

1: Guowei Che, E-mail: [email protected]

20

2: Jian Huang, E-mail: [email protected]

21

Tel. & Fax number: +86-2885422494

22

Address: No. 37 Guoxue Road, Wuhou Area, Chengdu, P.R. China

23

Page 2

ACCEPTED MANUSCRIPT 24

Author contributions Yutian Lai, Jian Huang and Guowei Che made substantial contributions to the conception and

26

design of the work; Yutian Lai and Jian Huang drafted the work and revised it critically for important

27

intellectual content; Jing Liu contributed to the acquisition, analysis and interpretation of the data; and

28

Jianhua Su and Mei Yang contributed rehabilitation technology assistance and guidance.

RI PT

25

AC C

EP

TE D

M AN U

SC

29

Page 3

ACCEPTED MANUSCRIPT 30

Abstract

31

Background As a newly developed treatment, preoperative pulmonary rehabilitation (PR) has been studied in

33

depth. However, few studies have assessed the relationship between advanced age and a shorter-term

34

intensive pattern of preoperative PR in patients with lung cancer (LC), and especially those patients

35

waiting for therapeutic LC surgeries. This study investigated short-term preoperative PR combined with

36

inspiratory muscle training (IMT) and aerobic endurance training in elderly patients scheduled to

37

undergo LC lobectomy.

38

Methods

M AN U

SC

RI PT

32

A prospective randomized controlled trial with a total of 60 subjects aged ≥70 was conducted. The

40

intervention group (PR group) was treated for one week with systematic and highly intensive

41

preoperative PR training before lobectomy, and the control group (NPR group) was treated with

42

conventional preoperative respiratory management. We analyzed the 6-min walking distance (6-MWD),

43

the peak expiratory flow (PEF), and quality-of-life scores before and after the rehabilitation regimen as

44

well as the incidence of postoperative pulmonary complications (PPCs).

45

Results

EP

In total, 30 patients (PR group) completely executed the 7-day intensive preoperative PR, and 30

AC C

46

TE D

39

47

patients (NPR group) served as the control group. The two groups were comparable at baseline. During

48

the preoperative PR, a significantly longer 6-MWD (increase: 28.6±18.2 vs. 9.4±27.0 m;

49

between-groups difference: 19.2 m, P=0.029) and an increased PEF (increase: 26.2±22.5 vs. 8.2±10.3

50

L/min; between-groups difference: 18.0 L/min, P<0.001) were noted in the PR group compared with the

51

NPR group. After LC surgery, the mean postoperative length of stay (6.9±4.4 vs. 10.7±6.4 days,

52

P=0.010) and total hospital stay (16.0±4.5 vs. 19.7±6.5 days, P=0.012) were significantly reduced in the

Page 4

ACCEPTED MANUSCRIPT 53

PR group. Thirty-day PPCs were noted in 4 (13.3%) patients in the PR group and 11 (36.7%) patients in

54

the NPR group, with a significant difference between the two groups (P=0.037).

55

Conclusions For elderly LC patients scheduled to undergo surgery in China, a 7-day intensive pattern of

57

preoperative PR combined with IMT and aerobic endurance training may be a feasible rehabilitation

58

strategy with positive physical and psychological effects.

59

Key Words: elderly, preoperative pulmonary rehabilitation, lung cancer.

62

SC

M AN U

60 61

RI PT

56

Introduction

Malignant tumors are the most health- and life-threatening disease in humans, and lung cancer (LC) ranks first among all tumors in China in terms of its morbidity rate [1, 2]. Surgical resection remains the

64

optimal treatment for resectable LC, particularly for pre-malignant and early lesions [3]. However, the

65

postoperative pulmonary complication (PPC) rate remains high, which has an adverse effect on surgical

66

outcomes.

TE D

63

Among LC patients, the elderly are at high risk of PPCs due to poor lung fitness, cardiopulmonary

68

intolerance and more comorbidities compared with younger individuals. Further clinical trials are

69

needed to confirm the safety and efficacy of preventive and therapeutic approaches (including

70

pulmonary rehabilitation (PR) programs) in the elderly. To improve postoperative outcomes, there has

71

been growing interest in the role of preoperative PR over the past decade. Our previous clinical

72

experiments demonstrated that systematic, highly intensive rehabilitation could be an effective

73

treatment, providing positive physical and psychological effects on surgical patients [4-6].

74

AC C

EP

67

Based on this finding, we hypothesized that systemic, intensive preoperative rehabilitation may

Page 5

ACCEPTED MANUSCRIPT

play an impactful role in improving cardiopulmonary intolerance and subsequently reducing the PPC

76

rate. This pattern may perhaps be a feasible and practical treatment for elderly patients. Thus, in this

77

study, a prospective randomized trial was conducted to evaluate the effects of a modified combined PR

78

program that integrates respiratory exercise and physical rehabilitation within a short period before LC

79

lobectomy in patients ≥70 years of age.

RI PT

75

Materials and Methods

82

Study subjects and grouping

M AN U

81

SC

80

A prospective randomized controlled trial (RCT) with a total of 127 subjects was conducted in the

84

Department of Thoracic Surgery, West China Hospital, between June 2015 and March 2016. During the

85

study, patients were screened according to the inclusion/exclusion criteria (Table 1) and were randomly

86

allocated into the PR or control (non-pulmonary rehabilitation, NPR) group (Figure 1).

87

Inclusion/exclusion criteria:

TE D

83

All included patients had a definite diagnosis of primary non-small-cell LC (NSCLC) based on

89

preoperative pathological examination and preoperative imageological examinations according to

90

NSCLC diagnosis and treatment guidelines, had no surgical contraindication to and were willing to

91

undergo video-assisted thoracic surgery (VATS) or traditional thoracotomy (open) lobectomy, and

92

agreed to receive preoperative PR.

AC C

93

EP

88

Patients with contraindications or risk factors for adverse events, such as a history of myocardial

94

infarction, cerebrovascular accident (<1 year), unstable angina pectoris, aneurysm, hemoptysis (<90

95

days), severe arrhythmia or musculoskeletal or mental disorders, were excluded. In addition, patients

96

with SpO2 <90% during the 6-min walking test; with an absence of NSCLC, as confirmed by

Page 6

ACCEPTED MANUSCRIPT 97

postoperative pathological examination; or with sub-lobar resection or pneumonectomy were also

98

excluded.

99

Preoperative PR program The program was primarily a physical intervention focusing on exercise endurance training and

101

inspiratory muscle training (IMT). All participants were assessed, and data were recorded by a

102

physiotherapist who was blinded to the grouping and the study purpose.

RI PT

100

The preoperative PR procedure was as follows:

104

On the first day, the 6-min walking distance (6-MWD) test and the pulmonary function test (PFT)

105

were performed to assess the patients’ initial cardiopulmonary function. The 6-MWD test was

106

performed as suggested by the American Thoracic Society Pulmonary Function Standards Committee.

107

Health-related quality of life (HRQoL) was evaluated in both groups and recorded using a chart based

108

on EORTC QLQ-C30 & LC13_CN (version 3), both of which have a score scale ranging from 0 to 100.

109

A high score on these disease-specific HRQoL instruments used for oncology patients reflects either a

110

good state of function or a high intensity of symptoms [7].

TE D

M AN U

SC

103

Daily activities included IMT (performed in the ward) and aerobic endurance training (performed

112

in the rehabilitation training center), as follows: 1). Abdominal breathing training: The diaphragm

113

muscles were strengthened through this exercise (twice per day at 15 to 20 min each). The patients

114

slowly inhaled to their maximum lung capacity through their nose, held their breath for a short period,

115

and then exhaled slowly through their lips with their abdominal muscles tightened. 2). Expiration

116

exercise: A simple respiratory training device (Voldyne 5000, Sherwood Medical Supplies, St. Louis,

117

MO, USA) was used for this training. The patients were guided to exhale calmly at the beginning, to

118

then deeply inhale through the suction nozzle of the training device, and to finally exhale slowly after

AC C

EP

111

Page 7

ACCEPTED MANUSCRIPT

holding their breath for several seconds. The training pattern was performed 3 times per day for 20 min

120

each. 3). Aerobic endurance training: The NuStep device (NuStep, Inc. Ann Arbor, MI) was used in the

121

rehabilitation training center for this purpose. The patients adjusted the resistance gear range according

122

to their own speed and power at first and then increased the resistance range progressively. During the

123

training, the procedure was stopped if the patients had any obvious discomfort, such as shortness of

124

breath, dyspnea or exhaustion. The patients were allowed to rest until their condition could withstand

125

subsequent training. This pattern lasted 30 min daily.

SC

RI PT

119

At the end of the 7-day PR, the 6-MWD test, PFT and EORTC QLQ-C30 & LC13_CN (version 3)

127

were performed again to complete the program. In addition, the NPR group underwent the same

128

assessments before the surgery.

129

Outcome measures

M AN U

126

Thirty-day PPCs were identified and recorded based on the medical records, and the data collection

131

was blinded for the purpose of the study design. We used the Clavien-Dindo complication classification

132

system to classify the PPCs into five grades, and the PPCs were ultimately defined as Clavien-Dindo

133

grade II to grade V. The EORTC QLQ-C30 and EORTC LC13_CN were used to assess patient

134

symptoms and HRQoL. Additional data collected included the 6-MWD and peak expiratory flow (PEF).

136 137

EP

AC C

135

TE D

130

Data analysis

The primary endpoint of the study was reduction of the PPC rate. The type I error rate (α) was set

138

as 5%, with 80% statistical power. We expected to produce a 30% difference in the PPC rate. The

139

calculation was based on unpublished study data (n=176), which revealed an 8.5% PPC rate in the PR

140

group. With a one-sided alternative, we needed to include 30 patients in each group.

Page 8

ACCEPTED MANUSCRIPT

All continuous variables are presented as the mean ± standard deviation (SD); non-normally

142

distributed data, as the median and range; and binary variables, as a proportion. Among continuous

143

variables, discrete variables were analyzed using the chi-square test or Fisher’s exact test. All results

144

were considered significant at P<0.05. Statistical analyses were performed using SPSS software V.21.0.

RI PT

141

146

Results

147

Study population and characteristics

SC

145

A total of 127 patients were screened for participation, and 67 were excluded from the study.

149

During the PR, 38 patients did not meet the inclusion criteria, 22 refused to participate in the regimen,

150

and 7 quit for various reasons. Therefore, 60 patients were ultimately included in the study. The two

151

groups were comparable in terms of demographic and surgical characteristics and baseline outcome

152

variables. All differences between the groups were non-significant (Table 2).

153

Safety considerations and adverse events

TE D

M AN U

148

During the study, 4 patients in the PR group suspended the training because they could not endure

155

the highly intensive regimen, 1 perceived a lack of benefit, and 1 suffered from knee pain. According to

156

the intention-to-treat principle, we included those who did not complete the regimen in the final

157

analysis.

158

Endpoint outcomes

160

AC C

159

EP

154

The mean postoperative length of stay (6.9±4.4 vs. 10.7±6.4 days, P=0.010) and total in-hospital

stay (16.0±4.5 vs. 19.7±6.5 days, P=0.012) were significantly reduced in the PR group (Table 2).

161

The increased 6-MWD (increase: 28.6±18.2 vs. 9.4±27.0 m; between-groups difference: 19.2 m,

162

P=0.029) and PEF (increase: 26.2±22.5 vs. 8.2±10.3 L/min; between-groups difference: 18.0 L/min

Page 9

ACCEPTED MANUSCRIPT

P<0.001) in the PR group were significantly different compared with the parameters in the NPR group.

164

However, no differences in other PFT indexes, including forced vital capacity (FVC; between-groups

165

difference: -0.01 L; P=0.795), forced expiratory volume in one second (FEV1; between-groups

166

difference: -0.02 L; P=0.146), and diffusion capacity of the lung for carbon monoxide (Dlco;

167

between-groups difference: -0.28 mL/min/mmHg; P=0.452), were observed between the groups (Table

168

3).

RI PT

163

Regarding QoL assessment, no difference was observed between the groups in terms of global

170

QoL (between-groups difference: -0.5; P=0.785), physical function (between-groups difference: -0.67;

171

P=0.691), emotional function (between-groups difference: -2.2; P=0.206) or the dyspnea score

172

(between-groups difference: 0.37; P=0.808) (Table 3).

M AN U

SC

169

Data on PPCs occurring in 30 days were available for all participants and were classified using the

174

Clavien-Dindo complication classification system. We included grades II to V to calculate PPC rates for

175

grade I PPCs that had limited clinical significance. A total of 4 patients (13.3%) in the PR group and 11

176

patients (36.7%) in the NPR group developed PPCs, with a significant difference noted between the two

177

groups (P=0.037). Pneumonia was the main postoperative pulmonary complication (18.3%, 11/60)

178

(Table 4).

180 181

EP

AC C

179

TE D

173

Discussion

This prospective randomized study depicted the effect of short-term preoperative PR in elderly LC

182

patients. The main intervention treatment in this study was a modified preoperative PR program

183

combined with IMT and aerobic endurance training. Inspiratory training has a long history of research,

184

especially among patients with chronic obstructive pulmonary disease (COPD), asthma, or poor lung

Page 10

ACCEPTED MANUSCRIPT

function. This training has been proven effective for improving inspiratory muscle strength and

186

endurance, functional exercise capacity, dyspnea symptoms and QoL [8-11], and a randomized study

187

published in JAMA demonstrated that two weeks of preoperative IMT could reduce the incidence of

188

PPCs following thoracic surgery [12]. Enhanced inspiratory muscle strength is thought to be a

189

determinant of functional capacity after thoracic surgery [13]. Moreover, with regard to aerobic

190

endurance training, despite being a multifactorial determinant, a recent study showed that this parameter

191

could represent disease severity and clinically relevant exercise tolerance in pediatric pulmonary arterial

192

hypertension [14] to preserve the ejection fraction in patients with heart failure [15]. Another study

193

demonstrated that quadriceps strength could be successfully improved, as confirmed by pathology, by

194

conventional early postoperative PR [16]. In summary, the reasons above provide reliable support for

195

our use of IMT and aerobic endurance as interventions in the preoperative rehabilitation setting. We

196

hypothesized that shorter-term intensive treatment with IMT in combination with aerobic endurance

197

training in elderly patients could be a better strategy than conventional care.

TE D

M AN U

SC

RI PT

185

Regarding the duration of preoperative PR, a few studies have investigated the correlation with

199

efficiency and duration. Frésard et al. reported that the acceptable duration for significantly improving

200

respiratory muscle strength and the recovery of pulmonary function was 3 to 15 days [17, 18].

201

Meanwhile, Yasuo et al. reported a duration of two weeks [18], and Benzo et al. concluded that a

202

four-week duration was optimal [8]. In China, one week is the maximum time period that may be

203

acceptable before an operation, as a longer duration may reduce patient compliance. Before further

204

analyzing this notion, it is important to note that this social phenomenon may be due to two aspects.

205

First, a deficiency in adequate community health care and public health consciousness may be present,

206

which is most clearly observed in patients from struggling economic areas. Deficiencies in basic-level

AC C

EP

198

Page 11

ACCEPTED MANUSCRIPT

hospitals and the primary care system make it infeasible and impracticable for patients to undergo

208

rehabilitation either at home or in community hospitals. Additionally, LC patients generally spend 7 to

209

10 days preparing for surgery, including completing the diagnostic process and finishing surgery-related

210

examinations, because of the inadequate equipment and technical skills at basic institutions. Second,

211

this effect may be mainly due to economics and currently misunderstood problems in medical ethics,

212

seriously exacerbating psychological resistance to spending 7 days or more in completing a

213

rehabilitation plan, although this is not yet an official viewpoint. Thus, in our study, based on our

214

previous experience, we set duration of 7 days for intensive PR for all PR-group patients. This duration

215

may allow achievement of effective PR and may also balance the contradictions of patient compliance

216

and patient economic support.

217

M AN U

SC

RI PT

207

PPCs are the major evaluation index for assessing the effect of PR in the short or long term. With

219

the rapid development of surgical technology, medical apparatuses and instruments, and antibiotics

220

since the 1970s and given that thoracoscopic procedures are associated with a lower risk of PPCs

221

compared with open thoracotomy, it is surprising that the rates and types of PPCs associated with lung

222

surgery have remained high [5]. However, intensive PR may reduce the incidence of PPCs [16, 21].

223

This effect is mainly attributed to the fact that PPCs vary widely across studies and have no

224

standardized global classification [22]. Fortunately, a recent meta-analysis demonstrated that

225

preoperative exercise-based PR can reduce the incidence of postoperative complications [4], which is

226

thought to be a mixed outcome based on physical and psychological evidence. For instance, in our study,

227

we found that an intensive physical intervention could improve exercise tolerance with correct guidance

228

[16]. Additionally, the increasing intensity of our modified PR program could build more

AC C

EP

TE D

218

Page 12

ACCEPTED MANUSCRIPT

self-confidence in patients following surgical stress. Moreover, the incidence of PPCs in the PR group

230

was reduced compared with that in the NPR group, and a significant difference was noted between the

231

two groups; these findings indicate that the comprehensive short-term rehabilitation regimen could be

232

an effective and feasible rehabilitation strategy for surgical patients with LC, and particularly elderly

233

patients, given their poor lung fitness, cardiopulmonary intolerance and increased comorbidities.

234

RI PT

229

During the preoperative PR process, we observed differences in the 6-WMD and PEF between the groups. As an index, the 6-MWD exhibits a close correlation with peak oxygen consumption (peak VO2)

236

and serves as an excellent prediction of reduced peak VO2 [22]. Another study summarized this index

237

as reflecting the disease severity and clinically relevant exercise tolerance [14]. Another indicator, PEF,

238

is an index used as a measurement of huff strength [24]. Huff is considered a more effective method

239

compared with cough in improving the clearance ability of endotracheal hypersecretion [25], and both

240

of these processes are necessary defenses against respiratory tract infection that aid in reducing the

241

incidence of complications. The enhancement of the PEF and 6-MWD reflect the improvement of

242

exercise tolerance and the clearance ability of endotracheal hypersecretion in the intervention group,

243

and these findings might have indicated that a reduced PPC rate would occur. Interestingly, the overall

244

length of stay and the postoperative length of stay were significantly reduced in the PR group compared

245

with the NPR group. The potential reasons for this finding may include fewer PPCs and better

246

postoperative recovery in the intervention group, which led to a shorter postoperative hospital stay.

M AN U

TE D

EP

AC C

247

SC

235

This study also has certain limitations that cannot be disclaimed or ignored. First, all the

248

participants in this study were enrolled via a single regional medical center in southwest China, so the

249

sample was just a small part of the related population that was surgically treated in our department. This

250

limitation might have led to type II statistical error for the patient cohort baseline characteristics, though

Page 13

ACCEPTED MANUSCRIPT

in the study, the groups were comparable in in terms of baseline characteristics. However, the

252

center-specific bias included in this study design is undeniable. In addition, racial differences and

253

regional disparities, and especially differences in the incidence of PPCs among groups, nations and

254

races, were not considered in the study, which may have partly influenced the study’s accuracy. Second,

255

in the process of the patient selection, we excluded several patients for various reasons. For example,

256

patients who refused to participate were not included, which may have inevitably confounded the results

257

and limited the generalizability of the conclusions. We also set an age of ≥70 years as an inclusion

258

criterion, and several of the enrolled individuals exhibited certain risk factors, such as COPD, a

259

smoking history, and critical PFT values. These confounders made it more difficult to perform a

260

subgroup analysis. Third, pulmonary function before and after PR is controversial, and a study

261

published in JAMA showed that short-term preoperative PR could improve pulmonary function in

262

patients who underwent coronary artery bypass graft surgery [26]; however, no difference regarding

263

PFT results, except PEF, was observed in our study.

264 265

Conclusions

EP

TE D

M AN U

SC

RI PT

251

Our study showed that the combined preoperative PR program played a positive physical role in

267

improving the PEF and 6-MWD in elderly surgical patients with LC while significantly reducing the

268

postoperative length of stay. We thus consider the 7-day intensive pattern of preoperative PR to be a

269

feasible rehabilitation strategy for elderly LC patients in China.

AC C

266

270 271 272

Ethics Statement and Informed Consent This exploratory randomized study was approved by the West China Hospital of Sichuan

Page 14

ACCEPTED MANUSCRIPT

University Clinical Trials and Biomedical Ethics Committee and the Chinese Ethics Committee of

274

Registering Clinical Trials (UIN Number: ChiCTR-IOR-16008109). All patients signed informed

275

consent forms before the information could be obtained.

276

Acknowledgments

RI PT

273

The authors thank all the personal trainers and physiotherapists for their work during the study

278

process; Dr. Hongxia Zhou for patient recruitment; and the nurses Dan Ma, Zhihua Xu and Juan Chen

279

for nursing care support. We also thank all the participants for their kind participation and cooperation.

280

Funding/Support

282

This study was funded by two project grants (No. 2014SZ0148 and No. 2015SZ0158) from the Foundation of Science and Technology Support Plan, Department of Sichuan Province, China.

283

TE D

The authors have no conflicts of interest to disclose.

EP

285

Conflict of Interest Statement

AC C

284

M AN U

281

SC

277

Page 15

ACCEPTED MANUSCRIPT 286

References

287

1.

Oncol. 2012; 23: x320–x327. 2.

Zheng RS, Zeng HM, Zhang SW. lung cancer incidence and mortality in China, 2010. Thorac

RI PT

288 289

Vansteenkiste J, Dooms C, Mascaux C, et al. Screening and early detection of lung cancer. Ann

Cancer. 2014; 5: 330–336.

290 3.

Onugha OI, Lee JM. Surgical Treatment of Lung Cancer. Cancer Treat Res. 2016; 170: 77-104

292

4.

Sebio Garcia R, Yáñez Brage MI, Giménez Moolhuyzen E, et al., Functional and postoperative

SC

291

outcomes after preoperative exercise training in patients with lung cancer: a systematic review and

294

meta-analysis. Interact Cardiovasc Thorac Surg. 2016; pii: ivw152.

295

5.

M AN U

293

Gao K, Yu PM, Su JH, et al. Cardiopulmonary exercise testing screening and preoperative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after

297

lung cancer surgery: A study for 342 cases. Thorac Cancer. 2015; 6: 443-9.

298

6.

TE D

296

Arbane G, Tropman D, Jackson D, et al. Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength

300

and exercise tolerance: randomised controlled trial. Lung Cancer. 2011; 71: 229-34. 7.

health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients

302

participating in randomized controlled trials. Support Care Cancer. 2011; 19: 1753-60.

303 304

8.

307

Benzo R, Wigle D, Novotny P, et al. Preoperative pulmonary rehabilitation before lung cancer

resection: results from two randomized studies. Lung Cancer. 2011; 74: 441-5.

305 306

Maringwa JT, Quinten C, King M, et al. Minimal important differences for interpreting

AC C

301

EP

299

9.

Crandall K, Maguire R, Campbell A, et al. Exercise intervention for patients surgically treated for Non-Small Cell Lung Cancer (NSCLC): a systematic review. Surg Oncol. 2014; 23: 17-30.

Page 16

ACCEPTED MANUSCRIPT 308

10. Yamana I, Takeno S, Hashimoto T, et al. Randomized Controlled Study to Evaluate the Efficacy of

309

a Preoperative Respiratory Rehabilitation Program to Prevent Postoperative Pulmonary

310

Complications after Esophagectomy. Dig Surg. 2015; 32: 331-337. 11. Stefanelli F, Meoli I, Cobuccio R, et al. High-intensity training and cardiopulmonary exercise

312

testing in patients with chronic obstructive pulmonary disease and non-small-cell lung cancer

313

undergoing lobectomy. Eur J Cardiothorac Surg. 2013; 44: e260-5.

RI PT

311

12. Hulzebos EH, Helders PJ, Favié NJ, et al. Preoperative Intensive Inspiratory Muscle Training to

315

Prevent Postoperative Pulmonary Complications in High-Risk patients Undergoing CABG Surgery.

316

JAMA. 2006; 296: 1851-7.

M AN U

SC

314

13. Stein R, Maia CP, Silveira AD, et al. Inspiratory muscle strength as a determinant of functional

318

capacity early after coronary artery bypass graft surgery. Arch Phys Med Rehabil. 2009; 90:

319

1685-91.

TE D

317

14. Douwes JM, Hegeman AK, van der Krieke MB, et al. Six-minute walking distance and decrease in

321

oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension. Int

322

J Cardiol. 2016; 202: 34-9.

324 325

15. Zotter-Tufaro C, Mascherbauer J, Duca F, et al. Prognostic Significance and Determinants of the

AC C

323

EP

320

6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2015; 3: 459-66.

326

16. Arbane G, Tropman D, Jackson D, et al. Evaluation of an early exercise intervention after

327

thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength

328

and exercise tolerance: randomised controlled trial. Lung Cancer. 2011; 71: 229-34.

329

17. Shiono, S, Abiko M, and Sato T. Postoperative complications in elderly patients after lung cancer

Page 17

ACCEPTED MANUSCRIPT 330

surgery. Interact Cardiovasc Thorac Surg. 2013; 16: 819-23. 18. Sekine Y, Chiyo M, Iwata T, et al. Perioperative rehabilitation and physiotherapy for lung cancer

332

patients with chronic obstructive pulmonary disease. Jpn J Thorac Cardiovasc Surg. 2005; 53:

333

237-43.

336 337

factors among city, township and rural area adults in China. BMJ Open. 2015; 5: e008417.

20. Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition—An ESPEN Consensus Statement. Clin Nutr. 2015; 34: 335-40.

SC

335

19. Zou Y, Zhang R, Zhou B, et al. A comparison study on the prevalence of obesity and its associated

M AN U

334

RI PT

331

338

21. Pehlivan E, Turna A, Gurses A, et al. The Effects of Preoperative Short-term Intense Physical

339

Therapy in Lung Cancer Patients: A Randomized Controlled Trial. Ann Thorac Cardiovasc Surg.

340

2011; 17: 461-468.

342

22. Dindo D, Demartines N, Clavien PA, et al. Classification of surgical complications: a new proposal

TE D

341

with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205-13. 23. Kehmeier ES, Sommer MH, Galonska A, et al. Diagnostic value of the six-minute walk test

344

(6MWT) in grown-up congenital heart disease (GUCH): Comparison with clinical status and

345

functional exercise capacity. Int J Cardiol. 2016; 203: 90-7.

347 348 349

AC C

346

EP

343

24. Hasani A, Pavia D, Agnew JE, et al. Regional mucus transport following unproductive cough and forced expiration technique in patients with airways obstruction. Chest. 1994; 105: 1420-5.

25. Ishida H, Kobara K, Osaka H, et al. Correlation between Peak Expiratory Flow and Abdominal Muscle Thickness. J Phys Ther Sci. 2014; 26: 1791-3.

350

26. Hulzebos EH, Helders PJ, Favié NJ, et al. Preoperative Intensive Inspiratory Muscle Training to

351

Prevent Postoperative Pulmonary Complications in High-Risk Patients Undergoing CABG Surgery.

Page 18

ACCEPTED MANUSCRIPT 352

JAMA. 2006; 296:1851-7.

AC C

EP

TE D

M AN U

SC

RI PT

353

Page 19

ACCEPTED MANUSCRIPT 354

Figure Legend

355

Figure 1: Eligibility and allocation of the study population

AC C

EP

TE D

M AN U

SC

RI PT

356

Page 20

ACCEPTED MANUSCRIPT 357 358

Table 1

SC

RI PT

Inclusion and exclusion criteria Inclusion Age ≥70 Primary NSCLC Underwent LC lobectomy Exclusion SpO2 <90% during the 6-min walking test No NSCLC Did not receive surgery High risk of adverse events Myocardial infarction or cerebrovascular accident within one year Unstable angina pectoris Aneurysm Musculoskeletal or mental disorder

AC C

EP

TE D

M AN U

359 360

Page 21

ACCEPTED MANUSCRIPT Table 2: Clinical characteristics between groups

P-value

72.5±3.4

71.6±1.9

0.228

16 (53.3) 2.1±0.5 69.8±16.9 3.0±0.7 22.3±4.2 77.6± 25.0 2 (6.7) 6 (20.0) 5 (16.7) 3 (10.0)

18 (60.0) 2.0±0.6 62.7±18.8 3.0±0.7 21.7±3.9 72.3±16.4 3 (10.0) 5 (16.7) 4 (13.3) 2 (6.7)

0.602 0.380 0.127 0.981 0.579 0.339 1.000 0.739 1.000 1.000 0.240

16 (53.3) 10 (33.3) 3 (10.0) 1 (3.3)

RI PT

NPR group

18 (60.0) 10 (33.3) 2 (6.7) 0 (0)

M AN U

Age, mean ± SD Gender Male FEV1, L ppoFEV1% FVC, L Dlco, mL/min/mmHg ppoDlco% ASA score >3 Current smoking status COPD BMI >30 Clinical stage Stage I Stage II Stage III Stage IV Surgical approach VATS Open Average duration of in-hospital stay, days Preoperative, days Postoperative, days

PR group

SC

361 362

TE D

20 (66.7) 10 (33.3) 19.7±6.5 9.0±1.6 10.7±6.4

0.781 0.012 1.000 0.010

EP

The data are presented as the mean ± SD, median (range) or n (%). COPD: chronic obstructive pulmonary disease, defined as FEV1/FVC <70% and FEV1 <80% of predicted; BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; Dlco: diffusion capacity of the lung for carbon monoxide; ppoFEV1%: postoperative predicted FEV1%; ppoDLCO%: postoperative predicted DLCO%; VATS: video-assisted thoracic surgery.

AC C

363 364 365 366 367 368

21 (70.0) 9 (30.0) 16.0±4.5 9.0±1.1 6.9±4.4

ACCEPTED MANUSCRIPT Page 22

Table 3: Between-groups differences between baseline and post-intervention for 6-MWD, PFT and QoL

Outcome variable

PR group (n=30)

NPR group (n=30)

RI PT

369

Between-groups difference

After the exercise

Before the exercise

After the exercise

Difference (95% CI)

P-value

6-MWD, m

431.7±102.8

460.3±93.6

434.5.4±86.2

443.9±88.4

19.2 (2.1 to 36.3)

0.029

PFT FEV1, L FVC, L Dlco, mL/min/mmHg PEF, L/min QoL evaluation

2.1±0.5 3.0±0.7 22.3±4.2 351.7±132.3

2.2±0.5 3.1±0.6 22.9±4.8 377.8±130.5

2.0±0.6 3.0±0.7 21.7±3.9 372.0±101.2

2.0±0.6 3.1±0.7 22.0±3.7 380.1±102.8

-0.02 (-0.06 to 0.01) -0.01 (-0.11 to 0.08) -0.28 (-1.0 to 0.46 ) 18.0 (8.9 to 27.1)

0.146 0.795 0.452 <0.001

Global QoL*

69.7±13.9

71.3±13.6

69.7 ±12.7

69.8±12.1

-0.5 (-4.6 to 3.5)

0.785

Physical function*

88.9±6.4

89.4±6.3

88.5±7.1

88.0±7.6

-0.67 (-4.0 to 2.7)

0.691

Emotional function*

86.6±9.5

90.2±7.4

83.8±10.6

86.7±8.9

-2.2 (-5.7 to 1.3)

0.206

Dyspnea score

12.2± 17.9

7.3±14.0

8.7±14.8

11.3±17.3

0.37 (-2.7 to 3.4)

0.808

M AN U

TE D

EP

The data are presented as the mean ± SD. *Higher scores indicate better functioning (scaled from 0 to 100). †Lower scores indicate less dyspnea (scaled from 0 to 100). FEV1: forced expiratory volume in one second; FVC: forced vital capacity; Dlco: diffusion capacity of the lung for carbon monoxide; PEF: peak expiratory flow; 6-MWD: 6-min walking distance; QoL: quality of life.

AC C

370 371 372 373 374 375 376 377 378 379 380

SC

Before the exercise

Page 23

ACCEPTED MANUSCRIPT Table 4: PPC rate PR group

Complication grade

n=30

11 (36.7) 16 (53.3) 12 (40.0) 8 (26.7)

New rise in C-reactive protein or WBC count Positive blood cultures Atelectasis Pleural effusion Grade II Pneumonia Mechanical ventilation <48 h

7 (23.3)

9 (30.0)

4 (13.3) 6 (20.0) 4 (13.3) 4 (13.3) 4 (13.3) 2 (6.7)

Pleural effusion needing tube Atelectasis needing toilet bronchoscopy Grade III

1 (3.3) 2 (6.7) 2 (6.7)

EP

M AN U

2 (6.7) 1 (3.3 4 (13.3)

1 (3.3) 2 (6.7) 1 (3.3)

0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)

1 (3.3) 1 (3.3) 1 (3.3) 1 (3.3) 1 (3.3)

0 (0.0) 0 (0.0)

1 (3.3) 1 (3.3)

*PPCs were defined as grades II to V. ICU: intensive care unit; ARDS: adult respiratory distress syndrome.

AC C

5 (16.7) 5 (16.7) 6 (20.0) 8 (26.7) 7 (23.3) 1 (3.3)

1 (3.3) 1 (3.3) 0 (0.0)

TE D

Grade V Death

P-value 0.037 0.796

RI PT

4 (13.3) 15 (50.0) 10 (33.3) 9 (30.0)

Chylothorax Grade IV Return to ICU Pulmonary embolism ARDS or respiratory failure

385

n=30

PPC rate* Grade I New-onset purulent sputum Fever >38°C, no focus outside the lungs

Empyema Mechanical ventilation >48 h Bronchopleural fistula

382 383 384

NPR group

0.197

SC

381

0.389

1.000

1.000

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT